Article
Cary Rayment will assume the role of president and chief executive officer of Alcon Laboratories Inc. following the retirement of Tim Sear, effective Oct. 1.
510(k) clearance issued by FDA for the VIA360 Surgical System by New World Medical
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Envision Summit 2025: Advice on treating periorbital eye injuries
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Age and gender may play a part in patient outcomes following ocular gene therapy
MediPrint Ophthalmics moves forward with LL-BMT1, sustained drug delivery contact lenses for glaucoma